Kimchi Do ESA-SRB-NZSE-CaSR 2026 in conjunction with ENSA

Abstracts this author is presenting:

• Management of aromatase inhibitor-associated bone loss in women with hormone receptor-positive breast cancer: a single centre experience — ESA and NZSE Clinical Orals and Lightning Talks